Patent Analyst（特許分析・知的財産戦略）

Overview

This skill provides professional patent analysis and intellectual property (IP) strategy support. Helps organizations conduct prior art searches, evaluate patentability, analyze competitor patent portfolios, assess freedom-to-operate (FTO), and develop comprehensive IP strategies for competitive advantage.

Primary language: Japanese (default), English supported Patent Databases: USPTO, EPO, JPO, WIPO, Google Patents, Espacenet, PatentScope Analysis Tools: Patent citation analysis, technology landscape mapping, patent valuation Output format: Prior art reports, patentability opinions, FTO analysis, IP strategy recommendations, patent landscape reports

---

When to Use

Use this skill when you need to:

• Conduct novelty searches before patent filing
• Evaluate patentability of inventions
• Perform freedom-to-operate (FTO) analysis before product launch
• Analyze competitor patent portfolios
• Develop patent filing strategies
• Assess patent infringement risks
• Prepare patent prosecution responses (Office Actions)
• Conduct due diligence for M&A or licensing

Trigger phrases (EN): "patent search", "prior art", "patentability", "FTO analysis", "patent portfolio", "IP strategy", "patent landscape", "infringement risk", "Office Action response"

Trigger phrases (JP): "特許調査", "先行技術調査", "特許性評価", "FTO分析", "特許ポートフォリオ", "知的財産戦略", "侵害リスク評価", "拒絶理由通知対応"

---

Prerequisites

Required Knowledge

• Understanding of patent law basics (35 USC 101, 102, 103, 112 for US; corresponding laws for EP/JP/CN)
• Familiarity with patent classification systems (CPC, IPC)
• Basic Boolean search syntax

Environment Setup

Patent Database Access (Free):

• Google Patents - Most accessible, global coverage
• Espacenet - European Patent Office
• PatentScope - WIPO international applications
• J-PlatPat - Japan Patent Office

Commercial Tools (Optional, for advanced analysis):

• Derwent Innovation (Clarivate)
• Orbit Intelligence (Questel)
• PatBase (Minesoft)

Python Dependencies (for automation scripts):

# Install required packages
pip install requests beautifulsoup4 pandas openpyxl

---

Workflow

This skill provides four primary workflows:

1. Prior Art Search (Novelty Search) - Determine if invention is novel before filing
2. Freedom-to-Operate (FTO) Analysis - Identify infringement risks before product launch
3. Patent Portfolio Analysis - Assess competitor/acquisition target patent strength
4. Patent Prosecution Support - Respond to Office Action rejections

See Core Workflows section for detailed step-by-step procedures.

Quick Start Example

# Search Google Patents for prior art (example)
# Open browser and navigate to:
open "https://patents.google.com/?q=neural+network+image+segmentation&type=PATENT"

# Run patent search helper script (generates structured search report)
python3 scripts/patent_search_helper.py \
  --keywords "neural network,image segmentation,medical imaging" \
  --cpc "G06N3/08,G06V10/82" \
  --output prior_art_report.md

---

Output

This skill generates the following deliverables:

Output Type	Format	Description
Prior Art Report	Markdown/PDF	Search results, relevance ranking, feature comparison matrix
Patentability Opinion	Markdown	35 USC 102/103 analysis, filing recommendation, risk assessment
FTO Analysis Report	Markdown	Claim mapping, infringement risk matrix, design-around options
Patent Portfolio Analysis	Markdown/Excel	Technology segmentation, competitor benchmarking, valuation
Office Action Response	Markdown	Arguments against rejection, proposed claim amendments

Sample Output Structure

# Prior Art Search Report

## Executive Summary
- **Invention**: [Title]
- **Search Date**: [Date]
- **Conclusion**: [NOVEL / NOT NOVEL / CONDITIONAL]

## Search Strategy
- **Databases**: Google Patents, Espacenet, USPTO PatFT
- **Keywords**: [List]
- **Classifications**: [CPC codes]

## Key References (Top 10)
| # | Patent/Publication | Relevance | Key Features | Differences |
|---|-------------------|-----------|--------------|-------------|
| 1 | US10,123,456 | HIGH | ... | ... |

## Feature Comparison Matrix
[Detailed comparison table]

## Patentability Assessment
- **Novelty (35 USC 102)**: [Analysis]
- **Non-Obviousness (35 USC 103)**: [Analysis]

## Recommendations
[Filing strategy, claim drafting guidance]

---

Resources

Bundled References

• references/patent_search_methodology.md - Comprehensive search methodology guide
• references/claim_analysis_guide.md - Patent claim interpretation and mapping

Bundled Scripts

• scripts/patent_search_helper.py - Generate structured prior art search reports

External Resources

• USPTO Patent Classification
• EPO CPC Browser
• WIPO IP Services

---

Core Framework: Patent Analysis Process

Patent Lifecycle Stages

1. Invention Disclosure
   ↓
2. Prior Art Search (Novelty Search)
   ↓
3. Patentability Assessment
   ↓
4. Patent Application Drafting & Filing
   ↓
5. Patent Prosecution (Office Actions)
   ↓
6. Patent Grant
   ↓
7. Patent Maintenance & Enforcement
   ↓
8. Monetization (Licensing, Sale, Litigation)

Types of Patent Searches

1. Novelty Search (Patentability Search):

• Purpose: Determine if invention is novel before filing patent application
• Scope: Broad search across all prior art (patents, publications, products)
• Timing: Before filing patent application
• Key Question: "Has this been done before?"

2. Freedom-to-Operate (FTO) Search:

• Purpose: Identify patents that may be infringed by commercializing a product/technology
• Scope: Active patents (in-force) in target markets
• Timing: Before product launch or manufacturing
• Key Question: "Can we practice this technology without infringing third-party patents?"

3. Invalidity Search:

• Purpose: Find prior art to invalidate a competitor's patent (for defense or litigation)
• Scope: Any prior art predating the patent's priority date
• Timing: When threatened with infringement, during litigation, or pre-litigation strategy
• Key Question: "Is there prior art that can invalidate this patent?"

4. State-of-the-Art Search:

• Purpose: Understand technology landscape and trends
• Scope: Broad survey of patents and publications in a technology domain
• Timing: Strategic R&D planning, competitive intelligence
• Key Question: "What is the current state of technology in this field?"

5. Patent Portfolio Analysis:

• Purpose: Analyze competitor or acquisition target's patent portfolio
• Scope: All patents owned by entity (active, expired, pending)
• Timing: Competitive analysis, M&A due diligence, licensing negotiations
• Key Question: "What is the strength and value of this patent portfolio?"

---

Core Workflows

Workflow 1: Prior Art Search (Novelty Search)

Purpose: Conduct comprehensive search to determine if an invention is novel and non-obvious before filing a patent application.

Step 1: Understand the Invention

Invention Disclosure Meeting:

• Participants: Inventor(s), Patent Attorney/Agent, Patent Analyst
• Duration: 1-2 hours
• Objective: Understand technical details, problem solved, advantages, key features

Key Information to Gather:

## Invention Disclosure Template

### Title
[Descriptive title of invention]

### Technical Field
[E.g., "Machine learning for image recognition" or "Battery electrode materials"]

### Background Problem
- What problem does this invention solve?
- What are the limitations of existing solutions?
- Why are current approaches inadequate?

### Invention Summary (High-Level)
[2-3 sentences describing the core concept]

### Key Features / Novel Elements
1. [Feature 1: e.g., "Use of convolutional neural network with attention mechanism"]
2. [Feature 2: e.g., "Real-time processing on edge device"]
3. [Feature 3: e.g., "Adaptive learning without labeled data"]

### Advantages
- What benefits does this invention provide? (speed, accuracy, cost, efficiency, etc.)
- How does it improve over prior art?

### Embodiments / Variations
- Are there alternative ways to implement this invention?
- Broad vs. narrow interpretations?

### Commercial Application
- What products/services will use this invention?
- Target market and use cases?

### Prior Knowledge
- Are you aware of similar technologies or patents?
- Any relevant publications, products, or conferences?

### Priority Date
- Date of first conception or reduction to practice (for US provisional filing date determination)

Identify Search Concepts: Break invention into searchable concepts:

• Core Concept: Main technical idea (e.g., "neural network image segmentation")
• Technical Elements: Key components (e.g., "encoder-decoder architecture", "skip connections")
• Application Domain: Use case (e.g., "medical imaging", "autonomous vehicles")
• Functional Aspects: What it does (e.g., "real-time processing", "low latency")

Step 2: Develop Search Strategy

Search Strategy Components:

1. Keywords and Synonyms:

Core Concept: "Image Segmentation"
Synonyms: Image partition, pixel classification, semantic segmentation, instance segmentation

Technical Element: "Convolutional Neural Network"
Synonyms: CNN, deep learning, neural architecture, deep neural network

Application: "Medical Imaging"
Synonyms: Medical image analysis, diagnostic imaging, radiology, CT scan, MRI

2. Patent Classification Codes: Patent offices use classification systems to categorize inventions:

CPC (Cooperative Patent Classification) - Used by USPTO and EPO:

Example for "Machine Learning for Image Recognition":
- G06N 3/08 (Learning methods - Neural networks)
- G06V 10/82 (Image analysis - Machine learning)
- G06T 7/00 (Image analysis - general)
- A61B 6/00 (Apparatus for radiation diagnosis - if medical imaging)

IPC (International Patent Classification) - Used by WIPO:

Similar to CPC, but broader categories

How to Find Classification Codes:

1. Search a few relevant patents and check their classification codes
2. Use patent office classification search tools (USPTO CPC, EPO ECLA)
3. Browse classification hierarchy to identify related codes

3. Search Query Formulation:

Boolean Operators:
- AND: Both terms must be present
- OR: Either term can be present
- NOT: Exclude term
- NEAR/X: Terms within X words of each other
- Wildcards: * (any characters), ? (single character)

Example Query (Google Patents syntax):
("image segmentation" OR "semantic segmentation")
AND ("neural network" OR CNN OR "deep learning")
AND ("medical imaging" OR "CT scan" OR MRI)
NOT ("text segmentation")

Example Query (USPTO PatFT):
TTL/(image NEAR2 segment$) AND SPEC/(neural network OR deep learning)
AND CPC/(G06N3/08 OR G06V10/82)

Step 3: Conduct Search

Search Databases:

1. Free Databases:

• Google Patents (patents.google.com): Most user-friendly, includes US, EP, JP, WO, CN, KR
• Espacenet (worldwide.espacenet.com): European Patent Office, global coverage
• PatentScope (patentscope.wipo.int): WIPO database, international applications (PCT)
• USPTO PatFT (patft.uspto.gov): US Patent Full-Text database (advanced search)
• J-PlatPat (www.j-platpat.inpit.go.jp): Japan Patent Office (Japanese patents, English abstracts)

2. Commercial Databases (Paid, more powerful):

• Derwent Innovation (Clarivate): Enhanced abstracts, family data, citation analysis
• Orbit Intelligence (Questel): Advanced analytics, patent families, legal status
• PatBase (Minesoft): Comprehensive global coverage, AI-powered search
• LexisNexis TotalPatent: Legal status tracking, alerts

Search Workflow:

1. **Broad Search** (Cast wide net):
   - Use core keywords + classification codes
   - Review 50-100 patent titles and abstracts
   - Identify key patents (most relevant)

2. **Focused Search** (Refine):
   - Analyze key patents in detail
   - Extract additional keywords, classifications, inventors, assignees
   - Perform "forward citation" search (who cited these patents?)
   - Perform "backward citation" search (what do these patents cite?)

3. **Deep Dive** (Critical references):
   - Full-text review of 10-20 most relevant patents
   - Compare claims to your invention
   - Identify differences (points of novelty)

4. **Non-Patent Literature (NPL) Search**:
   - Google Scholar (scientific publications)
   - IEEE Xplore, ACM Digital Library (engineering)
   - Product manuals, conference papers, websites

Step 4: Analyze Prior Art

Prior Art Relevance Assessment:

| Reference | Relevance | Key Features Disclosed | Differences from Invention |
|-----------|-----------|------------------------|----------------------------|
| US10,123,456 | High | CNN for image segmentation, encoder-decoder | No attention mechanism, not real-time |
| US9,876,543 | Medium | Real-time image processing | Uses traditional CV (not deep learning) |
| EP3456789 | Medium | Medical image segmentation | Rule-based, no ML |
| Pub: Chen et al. (2018) | High | Attention mechanism in CNN | Not applied to medical imaging, no edge deployment |

**Legend**:
- **High**: Discloses multiple key features of invention
- **Medium**: Discloses some features but missing key elements
- **Low**: Related field but different approach

Feature Comparison Matrix (Invention vs. Prior Art):

| Feature | Our Invention | US10,123,456 | Pub: Chen 2018 | US9,876,543 |
|---------|---------------|--------------|----------------|-------------|
| CNN architecture | ✓ | ✓ | ✓ | ✗ |
| Attention mechanism | ✓ | ✗ | ✓ | ✗ |
| Real-time processing | ✓ | ✗ | ✗ | ✓ |
| Edge device deployment | ✓ | ✗ | ✗ | ✗ |
| Medical imaging application | ✓ | ✓ | ✗ | ✗ |

**Analysis**: No single prior art reference discloses all key features. Combination of US10,123,456 (CNN for medical imaging) + Chen 2018 (attention mechanism) comes closest, but neither teaches edge deployment for real-time processing.

**Conclusion**: Invention appears novel. Potential obviousness rejection based on combination, but teaching away from edge deployment in prior art (computational requirements).

Step 5: Patentability Opinion

Three Criteria for Patentability (US Patent Law 35 USC):

1. Novelty (35 USC 102): Invention must be new

• Question: Is there any single prior art reference that discloses all elements of the invention?
• Assessment: If yes → NOT NOVEL. If no → Proceed to non-obviousness.

2. Non-Obviousness (35 USC 103): Invention must not be obvious to person of ordinary skill in the art

• Question: Would it be obvious to combine prior art references to arrive at the invention?
• Factors (Graham factors):
  • Scope and content of prior art
  • Differences between prior art and claimed invention
  • Level of ordinary skill in the art
  • Secondary considerations (commercial success, long-felt need, unexpected results)
• Assessment: Consider whether prior art teaches or suggests combination

3. Utility (35 USC 101): Invention must be useful

• Question: Does the invention have a specific, substantial, and credible utility?
• Assessment: Usually not an issue for most inventions (exception: abstract ideas, laws of nature)

Patentability Opinion Template:

# Patentability Opinion

## Invention Title
[Title]

## Summary of Invention
[2-3 sentences]

## Prior Art Search Summary
- **Databases Searched**: Google Patents, USPTO PatFT, Espacenet, Google Scholar
- **Search Strategy**: Keywords + CPC classifications G06N3/08, G06V10/82
- **Date Range**: All available (focus on last 20 years)
- **References Reviewed**: 85 patents, 15 publications
- **Key References Identified**: 5 highly relevant (listed below)

## Key Prior Art References
1. US10,123,456 (Title: "Deep learning for medical image segmentation") - HIGH relevance
2. Pub: Chen et al., "Attention mechanisms in CNNs" (2018) - HIGH relevance
3. US9,876,543 (Title: "Real-time image processing") - MEDIUM relevance
4. [Additional references...]

## Novelty Analysis (35 USC 102)

**Conclusion**: **NOVEL**

**Rationale**: No single prior art reference discloses all elements of the claimed invention, specifically:
- No reference discloses the combination of:
  - CNN with attention mechanism (Element 1)
  - Real-time processing on edge device (Element 2)
  - Medical imaging application (Element 3)

US10,123,456 discloses Elements 1 and 3 but not Element 2.
Chen 2018 discloses Element 1 but not Elements 2 and 3.

## Non-Obviousness Analysis (35 USC 103)

**Conclusion**: **LIKELY NON-OBVIOUS** (Medium confidence)

**Rationale**:
- **Combination**: It may be argued that US10,123,456 + Chen 2018 renders the invention obvious (both teach attention-based CNNs for image analysis)
- **Teaching Away**: However, prior art teaches that attention mechanisms are computationally expensive and unsuitable for edge devices (see US9,876,543, col. 5, lines 12-18)
- **Unexpected Results**: Our invention achieves real-time performance on edge device despite computational complexity (benchmarks show 10x faster than prior art expectations)

**Risk**: Patent Examiner may issue obviousness rejection based on combination of US10,123,456 and Chen 2018. Response strategy would emphasize:
1. Teaching away from edge deployment in prior art
2. Unexpected performance results
3. Commercial success and long-felt need for real-time medical imaging on portable devices

## Recommendations

**Filing Strategy**: **RECOMMEND FILING** (with considerations)

**Recommended Actions**:
1. **File Patent Application**: Invention appears patentable, proceed with filing
2. **Claim Strategy**:
   - Independent claims: Broad claims covering CNN + attention + edge device
   - Dependent claims: Specific embodiments (medical imaging, real-time constraints, architecture details)
3. **Potential Prosecution Issues**:
   - Anticipate obviousness rejection (combination of US10,123,456 + Chen 2018)
   - Prepare evidence of unexpected results (performance benchmarks)
   - Consider experimental data to demonstrate non-obviousness
4. **International Filing**: Consider PCT application to preserve foreign filing rights

**Alternative Strategy** (if budget limited):
- Publish invention as defensive publication to prevent others from patenting (creates prior art)
- Maintain as trade secret if embodiment is not easily reverse-engineered (not recommended here since device can be analyzed)

**Estimated Cost** (US filing):
- Patent attorney fees: $8,000 - $15,000
- USPTO filing fees: $1,820 (small entity) / $3,640 (large entity)
- Prosecution (Office Action responses): $3,000 - $8,000
- Total to grant: $15,000 - $30,000

**Timeline to Grant**: 18-36 months (typical for USPTO, depends on art unit backlog)

---

**Prepared By**: [Patent Analyst Name]
**Date**: [Date]
**Review Status**: Preliminary opinion (recommend review by patent attorney before filing)

---

Workflow 2: Freedom-to-Operate (FTO) Analysis

Purpose: Identify patents that may be infringed by commercializing a product or technology, and assess risk.

FTO vs. Patentability Search

Key Differences:

| Aspect | Patentability Search | FTO Search |
|--------|----------------------|------------|
| **Purpose** | Can we get a patent? | Can we sell this product? |
| **Focus** | Novelty of invention | Risk of infringing others' patents |
| **Prior Art Scope** | All prior art (expired patents, publications, products) | Only ACTIVE patents (in-force) |
| **Geography** | Not critical (novelty is global concept) | CRITICAL (patents are territorial) |
| **Claims Analysis** | Compare invention to prior art | Compare product to patent claims |
| **Timing** | Before filing patent | Before product launch |

Step 1: Define Product/Technology Scope

Product Feature Analysis:

## Product Description: Portable Medical Imaging Device

### Core Features
1. **Hardware**:
   - Handheld ultrasound transducer
   - Edge computing processor (NVIDIA Jetson)
   - Wireless connectivity (Bluetooth 5.0)
   - Battery-powered (4-hour runtime)

2. **Software**:
   - CNN-based image segmentation algorithm
   - Real-time image processing (<100ms latency)
   - Cloud sync for image storage
   - DICOM format output

3. **Use Case**:
   - Point-of-care ultrasound imaging
   - Emergency room triage
   - Remote/rural healthcare settings

### Technical Specifications
- Image resolution: 512x512 pixels
- Frame rate: 30 FPS
- Weight: 450g
- Regulatory: FDA Class II medical device (510(k) pending)

Step 2: Identify Target Markets

Geographic Scope: FTO analysis must be conducted separately for each country where product will be manufactured, sold, or used.

Priority Markets (Example):

1. United States: Largest medical device market, high litigation risk
2. Europe (Germany, UK, France): Significant market, enforceable European Patents (EP)
3. Japan: Advanced healthcare system, strong patent protection
4. China: Manufacturing location (if applicable), growing market

Note: Patents are territorial (US patent only enforceable in US, EP patent in Europe, etc.)

Step 3: Conduct FTO Search

Search Strategy:

1. Focus on ACTIVE Patents Only:

Active = Patents that are:
- Granted (not just pending applications, though pending should be monitored)
- In-force (maintenance fees paid)
- Not expired (20 years from filing date for utility patents)

Filter:
- Status: Active/In-force
- Priority date: Within last 20 years (typical patent term)

2. Claim-Centric Search (vs. specification search): FTO analysis focuses on patent CLAIMS (legal definition of invention), not just description.

3. Search Query:

(handheld OR portable OR mobile) AND (ultrasound OR "medical imaging")
AND (edge OR "real-time" OR "image processing")
AND CPC/A61B8/00 (Ultrasound diagnosis)
AND jurisdiction:(US OR EP OR JP OR CN)
AND status:ACTIVE

4. Database Queries:

• Google Patents: Use "Status: Active" filter + jurisdiction filter
• Espacenet: Legal status search (use INPADOC legal status)
• Commercial Tools (Orbit, Derwent): More accurate legal status tracking

Step 4: Claim Mapping Analysis

Claim Mapping Process: For each potentially relevant patent, map its claims to your product features.

Claim Analysis Template:

## Patent: US10,234,567 (Active, expires 2038)
**Title**: Portable ultrasound device with real-time image processing
**Assignee**: MedTech Corp (competitor)
**Family**: EP, JP, CN equivalents (all active)

### Independent Claim 1 (Simplified)
"A portable medical imaging device comprising:
  (a) a handheld ultrasound transducer;
  (b) a processor configured to perform real-time image processing;
  (c) a wireless communication module; and
  (d) a battery power source."

### Claim Mapping to Our Product

| Claim Element | Our Product | Match? | Notes |
|---------------|-------------|--------|-------|
| (a) Handheld ultrasound transducer | ✓ Yes | **YES** | Our product has handheld transducer |
| (b) Processor for real-time image processing | ✓ Yes | **YES** | NVIDIA Jetson performs real-time processing |
| (c) Wireless communication module | ✓ Yes | **YES** | Bluetooth 5.0 module |
| (d) Battery power source | ✓ Yes | **YES** | 4-hour battery |

### Infringement Assessment
**LIKELY INFRINGEMENT** (All claim elements present in our product)

**Risk Level**: **HIGH**

### Potential Defenses / Design-Arounds
1. **Invalidity Challenge**: Search for prior art to invalidate this patent
   - Preliminary search found US9,123,456 (published 2 years before priority date) discloses handheld ultrasound with wireless connectivity
   - May be able to invalidate Claim 1 based on this prior art

2. **Non-Infringement Arguments**:
   - Review dependent claims (narrower scope)
   - Analyze claim language (does "processor configured to perform real-time image processing" require specific architecture?)
   - Check prosecution history (file wrapper estoppel - did patentee disclaim certain embodiments?)

3. **Design-Around Options**:
   - Remove wireless module? (Not practical - key product feature)
   - Use tethered design instead of battery? (Defeats portability advantage)
   - License from MedTech Corp (recommended approach if patent is valid)

### Licensing Strategy
- **Contact**: MedTech Corp for licensing discussion
- **Estimated Royalty**: 3-5% of product revenue (typical for medical device patents)
- **Negotiation Leverage**: Our patent application may provide cross-licensing opportunity

Step 5: Risk Assessment and Recommendations

FTO Risk Matrix:

| Patent | Assignee | Infringement Risk | Validity Risk | Priority | Recommended Action |
|--------|----------|-------------------|---------------|----------|---------------------|
| US10,234,567 | MedTech Corp | **HIGH** (All elements match) | Medium (potential prior art found) | **P1** | License negotiation + invalidity search |
| US10,456,789 | Siemens | MEDIUM (Most elements, unclear "real-time" threshold) | Low (strong patent) | **P2** | Design-around analysis (avoid "real-time" claim limitations) |
| US10,678,901 | GE Healthcare | LOW (Different ultrasound frequency range) | N/A | **P3** | Monitor (likely non-infringing) |

Risk Level Definitions:

• HIGH: Strong likelihood of infringement, valid patent → Immediate action required
• MEDIUM: Possible infringement, uncertain claim interpretation → Detailed analysis needed
• LOW: Unlikely infringement, significant differences → Monitor, no immediate action

FTO Opinion Summary:

# Freedom-to-Operate Opinion

## Product
Portable Medical Imaging Device (Model: PMI-2025)

## Geographic Scope
United States (primary market)

## Search Summary
- **Patents Reviewed**: 45 active US patents
- **High-Risk Patents Identified**: 1 (US10,234,567)
- **Medium-Risk Patents**: 2 (US10,456,789, US10,789,012)
- **Low-Risk Patents**: 5 (monitoring only)

## Overall Risk Assessment
**MEDIUM-HIGH RISK** (due to US10,234,567)

## Recommended Actions

### Priority 1: US10,234,567 (MedTech Corp)
**Action**: Licensing negotiation
**Rationale**: Likely infringement, licensing preferred over litigation risk
**Timeline**: Initiate contact within 30 days, before product launch
**Estimated Cost**: 3-5% royalty or one-time license fee $500K-$1M
**Alternative**: Conduct invalidity search (budget: $20K-$30K); if successful, may avoid licensing

### Priority 2: US10,456,789 (Siemens)
**Action**: Design-around analysis
**Rationale**: Possible infringement depending on "real-time" claim interpretation
**Timeline**: 60 days (complete before product launch)
**Estimated Cost**: $10K-$15K for detailed claim analysis and design-around engineering

### Priority 3: Monitor Low-Risk Patents
**Action**: Periodic FTO monitoring (quarterly updates)
**Rationale**: Patent landscape changes (new grants, litigation, licensing)

## Product Launch Recommendation
**CONDITIONAL PROCEED** (subject to actions above)

- **Do Not Launch** until Priority 1 (US10,234,567) is resolved (license or invalidity confirmed)
- **Proceed** with design-around for Priority 2 if feasible
- **Risk Tolerance**: If company has $5M+ litigation budget and willingness to challenge patents, may proceed with "design-around + prepared defense" strategy

## Insurance Recommendation
Consider **Patent Infringement Insurance** (Defense cost coverage: $1M-$5M, premiums: $50K-$150K/year)

---

**Prepared By**: [Patent Analyst]
**Date**: [Date]
**Reviewed By**: [Patent Attorney]
**Confidence Level**: Medium-High (based on available claim interpretation, subject to detailed legal analysis)

---

Workflow 3: Patent Portfolio Analysis

Purpose: Analyze competitor's or acquisition target's patent portfolio to assess strength, value, and strategic positioning.

Step 1: Portfolio Data Collection

Data Points to Collect:

## Portfolio Overview: [Company Name]

### Quantitative Metrics
- **Total Patents**: 1,250 (850 active, 400 expired/abandoned)
- **Pending Applications**: 180
- **Geographic Distribution**:
  - US: 450 patents
  - EP: 320 patents
  - JP: 180 patents
  - CN: 200 patents
  - Other: 100 patents
- **Filing Trend**: 80-100 new applications per year (last 5 years)
- **Grant Rate**: 75% (industry average: 65%)

### Portfolio Age Distribution
| Age | Count | % |
|-----|-------|---|
| 0-5 years | 320 | 38% |
| 6-10 years | 280 | 33% |
| 11-15 years | 150 | 18% |
| 16-20 years | 100 | 11% |

**Analysis**: Portfolio is relatively young (71% under 10 years old), indicating active R&D and recent innovation focus.

Step 2: Technology Segmentation

Patent Classification by Technology Area:

## Technology Breakdown (by CPC Classification)

| Technology Area | Patents | % of Portfolio | Strategic Importance |
|-----------------|---------|----------------|----------------------|
| Image Processing (G06T) | 380 | 45% | **Core** (company's primary business) |
| Machine Learning (G06N) | 220 | 26% | **Emerging** (growth area) |
| Medical Devices (A61B) | 180 | 21% | **Strategic** (new market entry) |
| User Interfaces (G06F 3) | 70 | 8% | **Supporting** |

**Key Insights**:
- **Concentrated Portfolio**: 45% in image processing (core competency, strong moat)
- **Emerging Bet**: 26% in machine learning (future growth driver)
- **Diversification**: Entering medical device market (21% of portfolio)

Patent Clustering (Topic Modeling): Use patent analytics tools to cluster patents by technical similarity:

Cluster 1: Real-time image segmentation (150 patents)
Cluster 2: 3D reconstruction from 2D images (90 patents)
Cluster 3: Edge device optimization (80 patents)
Cluster 4: CNN architectures for medical imaging (120 patents)
Cluster 5: Data augmentation techniques (60 patents)

Step 3: Competitor Benchmarking

Competitive Patent Landscape:

| Company | Total Patents | Annual Filings | Technology Focus | Portfolio Strength |
|---------|---------------|----------------|------------------|---------------------|
| **Target Company** | 1,250 | 90/year | Image processing, ML | Strong (Core) |
| Competitor A | 2,800 | 150/year | Broad (Imaging, AI, Robotics) | Very Strong (Diversified) |
| Competitor B | 850 | 60/year | Narrow (Medical imaging only) | Medium (Specialized) |
| Competitor C | 400 | 30/year | Adjacent (Data analytics) | Weak (Few patents) |

**Market Position**: Target Company is #2 in patent count, but #1 in medical imaging sub-segment (180 patents vs. Competitor A's 120 patents in medical).

Patent Citation Analysis:

Forward Citations (Who cites target company's patents?):
- Competitor A: 320 citations (frequent citation indicates fundamental patents)
- Competitor B: 180 citations
- Startups: 150 citations (technology diffusion to ecosystem)

Backward Citations (Who does target company cite?):
- Top cited entities: MIT (80 citations), Stanford (60 citations), IBM (50 citations)
→ Indicates strong academic research foundation and licensing from universities

Step 4: Patent Quality Assessment

Quality Metrics:

1. Claim Breadth:

• Narrow Claims: <5 independent claims, highly specific limitations → Easier to design around
• Broad Claims: Multiple independent claims, broad functional language → Stronger blocking power

Sample Patent Quality Scoring:

| Patent | Independent Claims | Claim Length (words) | Citation Count | Litigation History | Quality Score (1-10) |
|--------|--------------------|-----------------------|----------------|---------------------|----------------------|
| US10,123,456 | 3 | 45 (broad) | 25 (highly cited) | Enforced 2x | **9/10** (High) |
| US10,234,567 | 1 | 120 (narrow) | 5 (low citation) | None | **4/10** (Low) |
| US10,345,678 | 5 | 60 (medium) | 15 | None | **7/10** (Medium-High) |

2. Family Size (Number of countries where patent is filed):

• Large Family (10+ countries): Indicates high strategic value, significant investment
• Small Family (<5 countries): Lower value, defensive filing

3. Maintenance Status:

• Active + Fees Paid: Owner values the patent, likely being practiced
• Abandoned: Owner stopped paying fees → Patent may not be valuable or no longer practiced

Step 5: Valuation and Strategic Assessment

Patent Valuation Approaches:

1. Cost Approach:

Estimated R&D cost to develop patented technology + Patent prosecution costs

Example:
- R&D cost: $500K (engineer salaries, lab equipment, materials)
- Patent costs: $50K (filing + prosecution + maintenance over 10 years)
- Total: $550K per patent

Portfolio (1,250 patents) × $550K = $687M estimated cost

2. Market Approach:

Comparable patent sales or licensing deals in the industry

Example:
- Recent medical imaging patent portfolio (500 patents) sold for $250M
- Per-patent value: $500K
- Target portfolio (1,250 patents, similar quality): $625M estimated value

3. Income Approach (Most common for M&A):

Present value of future cash flows attributable to patents

Example:
- Product revenue attributable to patented technology: $100M/year
- Patent contribution (estimated): 15% of product value = $15M/year
- Discount rate: 10%
- Patent life remaining: 10 years average
- NPV = $15M × (1 - (1.1)^-10) / 0.1 = $92M

→ Portfolio value: $92M (conservative)

Strategic Value Assessment:

## Strategic Value (Beyond Financial)

### Offensive Value (Assertion Potential)
- **High**: 180 medical imaging patents cover emerging market (competitors likely infringe)
- **Medium**: 220 ML patents (broad field, harder to enforce)
- **Low**: 70 UI patents (design-arounds available)

### Defensive Value (Freedom to Operate)
- **Essential Patents**: 50 patents likely essential for anyone practicing real-time medical imaging
- **Blocking Power**: Strong portfolio prevents competitors from entering medical imaging without license

### Licensing Revenue Potential
- **Current**: $12M/year in licensing revenue (8 active licensees)
- **Potential**: $30M/year if aggressively licensed (estimated 20 additional licensees in market)

### Cross-Licensing Leverage
- Strong portfolio enables favorable cross-licensing deals with competitors (avoids cash payments)

### Acquisition Strategic Fit
- **If Acquiring**: Portfolio complements acquirer's existing patents (25% overlap, 75% additive)
- **If Target of Acquisition**: Portfolio is key asset (justifies 30-40% of acquisition premium)

---

Workflow 4: Patent Prosecution Support (Office Action Response)

Purpose: Respond to patent examiner's Office Action rejections to overcome objections and obtain patent grant.

Common Rejection Types

1. 35 USC 102: Novelty Rejection:

• Meaning: Examiner found prior art that discloses all elements of claimed invention
• Response Strategy: Argue differences, amend claims to distinguish from prior art

2. 35 USC 103: Obviousness Rejection:

• Meaning: Examiner argues combination of prior art renders invention obvious
• Response Strategy: Argue non-obviousness (teaching away, unexpected results, commercial success)

3. 35 USC 112: Enablement/Written Description Rejection:

• Meaning: Specification does not adequately describe or enable the invention
• Response Strategy: Argue specification discloses invention, or amend claims to match disclosure

4. 35 USC 101: Subject Matter Eligibility Rejection (Software/Business Methods):

• Meaning: Claimed invention is directed to abstract idea, law of nature, or natural phenomenon
• Response Strategy: Argue practical application, technological improvement

Office Action Response Template

# Response to Office Action

**Application Number**: 17/123,456
**Filing Date**: March 15, 2023
**First Named Inventor**: John Smith
**Title**: Real-Time Image Segmentation on Edge Device Using Attention-Based CNN
**Examiner**: Jane Doe
**Art Unit**: 2624

---

## Overview of Examiner's Rejections

The Office Action dated October 10, 2024 rejected Claims 1-15 under the following grounds:

1. **Claims 1, 2, 5-10**: Rejected under 35 USC 103 as obvious over US10,123,456 (Johnson) in view of US10,234,567 (Chen)
2. **Claims 3-4, 11-15**: Rejected under 35 USC 102(a)(1) as anticipated by US10,345,678 (Lee)

Applicant respectfully traverses these rejections and requests reconsideration.

---

## Response to 35 USC 103 Rejection (Claims 1, 2, 5-10)

### Examiner's Position (Summary)
The Examiner argues that it would have been obvious to combine:
- Johnson (US10,123,456): Discloses CNN-based image segmentation for medical imaging
- Chen (US10,234,567): Discloses attention mechanisms in CNNs

The Examiner states: "It would have been obvious to incorporate Chen's attention mechanism into Johnson's CNN segmentation system to improve accuracy." (Office Action, p. 3)

### Applicant's Response

**Respectfully, the Examiner's conclusion is not supported for the following reasons:**

#### Reason 1: Teaching Away from Combination

Johnson expressly teaches AWAY from using computationally expensive mechanisms like attention on edge devices:

> "Attention mechanisms, while effective, are unsuitable for resource-constrained edge devices due to their computational complexity (>10 GFLOPS), which exceeds typical edge processor capabilities (1-5 GFLOPS)." (Johnson, col. 8, lines 45-50)

This clear teaching away from the claimed combination contradicts the Examiner's obviousness rationale. One of ordinary skill in the art would be **discouraged** from combining Johnson and Chen based on Johnson's explicit guidance.

#### Reason 2: Unpredictable Results

The claimed invention achieves unexpected results not suggested by the prior art:

**Performance Comparison** (Attached as Exhibit A - Declaration of Dr. Smith):
| System | Inference Time (ms) | Accuracy (%) | Device |
|--------|---------------------|--------------|--------|
| Johnson (alone) | 120 | 88% | Edge device |
| Chen (alone) | 250 | 92% | Server GPU |
| **Claimed Invention** | **85** | **94%** | **Edge device** |

The claimed invention achieves:
- **Faster inference** than Johnson alone (85ms vs. 120ms) while incorporating attention (contradicting computational complexity concern)
- **Higher accuracy** than Johnson (94% vs. 88%)
- **Edge device deployment** unlike Chen (which requires server GPU)

These results are unexpected and would not have been predictable to one of ordinary skill in the art at the time of invention.

#### Reason 3: Secondary Considerations

**Commercial Success**: Since product launch (June 2024), Applicant has sold 5,000 units with >$10M revenue, capturing 15% market share in portable medical imaging segment.

**Long-Felt Need**: Prior to Applicant's invention, no commercially available edge-based real-time medical imaging device with CNN segmentation existed. The market had sought such a device for over 5 years (see market reports attached as Exhibit B).

**Industry Recognition**: Applicant's invention received "Most Innovative Medical Device" award from Medical Technology Association (2024) and has been cited in 12 subsequent patent applications by competitors.

These secondary considerations support non-obviousness of the claimed invention.

### Conclusion on 103 Rejection

For the foregoing reasons, Applicant respectfully submits that Claims 1, 2, 5-10 are not obvious over Johnson in view of Chen. The prior art teaches away from the claimed combination, the invention produces unexpected results, and secondary considerations strongly support non-obviousness.

**Respectfully request reconsideration and withdrawal of rejection.**

---

## Response to 35 USC 102 Rejection (Claims 3-4, 11-15)

### Examiner's Position
The Examiner asserts that Lee (US10,345,678) anticipates Claims 3-4, 11-15 by disclosing all elements of the claimed invention.

### Applicant's Response

**Respectfully, Lee does NOT anticipate the claimed invention** because Lee fails to disclose at least the following claim element:

**Disputed Claim Element (Claim 3)**:
> "wherein the attention mechanism is configured to dynamically weight feature maps based on spatial and channel-wise importance..."

**Lee's Disclosure** (cited by Examiner at col. 5, lines 10-20):
> "The system applies a fixed weighting matrix to feature maps to emphasize edge regions..."

**Analysis**: Lee's "fixed weighting matrix" is fundamentally different from the claimed "dynamically weight feature maps based on spatial and channel-wise importance":

| Aspect | Claimed Invention | Lee |
|--------|-------------------|-----|
| Weighting | **Dynamic** (changes per input) | **Fixed** (pre-defined matrix) |
| Basis | **Spatial AND channel-wise** | **Spatial only** (edge regions) |
| Adaptation | **Input-dependent** | **Static** |

A person of ordinary skill in the art would understand these as distinct approaches. Lee's fixed weighting matrix does not read on the claimed dynamic attention mechanism.

### Proposed Claim Amendment (If Necessary)

If the Examiner maintains the rejection, Applicant is willing to amend Claim 3 to further clarify:

**Amended Claim 3** (changes underlined):
> "wherein the attention mechanism is configured to **adaptively and dynamically** weight feature maps **in real-time** based on spatial and channel-wise importance **computed from input-specific features**..."

However, Applicant submits that this amendment is not necessary, as the original claim language is sufficiently distinct from Lee.

### Conclusion on 102 Rejection

For the foregoing reasons, Lee does not anticipate Claims 3-4, 11-15. **Respectfully request withdrawal of rejection.**

---

## Conclusion and Request

For all the reasons set forth above, Applicant respectfully submits that Claims 1-15 are patentable and requests reconsideration and withdrawal of all rejections.

Should the Examiner have any questions or wish to discuss this application, Applicant's attorney is available for an Examiner interview.

**Respectfully submitted,**

[Patent Attorney Name]
Registration No. [Number]
[Law Firm]
[Contact Information]

**Date**: November 15, 2024

---

**Attachments**:
- Exhibit A: Declaration of Dr. John Smith (Inventor) with performance benchmarks
- Exhibit B: Market reports evidencing long-felt need
- Exhibit C: Highlighted portions of Johnson and Chen references

---

Best Practices

1. Conduct Thorough Prior Art Searches

Don't skip the prior art search:

• Filing a patent without prior art search wastes money if invention is not novel
• Prior art search informs claim drafting strategy (avoid known art)
• Budget: $2,000-$5,000 for professional prior art search (worth the investment)

2. File Early, File Strategically

Priority Date is Critical:

• US: First-to-file system (not first-to-invent) - file ASAP after invention
• Consider provisional application ($1,800 filing fee) to establish priority date, then convert to non-provisional within 12 months

Strategic Filing:

• PCT (Patent Cooperation Treaty) application: Preserves foreign filing rights for 30 months while deferring costs
• Direct filing in key markets: US, EU, JP, CN (if budget allows)

3. Focus on Claim Quality

Claims Define the Invention (and enforce ability):

• Broad independent claims (capture core invention, harder for competitors to design around)
• Narrow dependent claims (fallback if broad claims are rejected)
• Functional language (what invention does) + structural language (how it's built)

4. Monitor Competitor Patents

Competitive Intelligence:

• Set up alerts for competitor patent publications (Google Patents, Espacenet alerts)
• Conduct annual FTO reviews (patent landscape changes)
• Track competitor litigation and licensing activities

5. Build a Strategic Portfolio

Portfolio Strategy:

• Core Patents: Protect key products and technologies (high value, defend at all costs)
• Blocking Patents: Prevent competitors from entering your space (may not practice yourself)
• Peripheral Patents: Improvements and variations (incremental value)
• Defensive Publications: Publish inventions you don't want to patent (creates prior art, prevents competitors from patenting)

---

Common Pitfalls

❌ Filing Too Late

Invention publicly disclosed before filing patent → Public disclosure becomes prior art (bars patentability in most countries except US 1-year grace period). Solution: File provisional application BEFORE any public disclosure (conference, publication, product launch).

❌ Ignoring FTO Analysis

Launching product without FTO analysis → Risk of patent infringement lawsuit after significant investment. Solution: Conduct FTO analysis 6-12 months before product launch, while design changes are still feasible.

❌ Abandoning Valuable Patents

Letting patents expire due to non-payment of maintenance fees → Lose exclusive rights. Solution: Implement patent docket management system, review portfolio annually, prune only truly low-value patents.

❌ Over-Drafting Claims

Filing patent with only narrow claims → Competitors easily design around. Solution: Include multiple claim scopes (broad independent + narrow dependent), cover embodiments and variations.

❌ Disclosing Trade Secrets in Patents

Filing patent on technology that should be trade secret → 20-year protection vs. indefinite trade secret protection (if reverse-engineering is difficult). Solution: Reserve patents for inventions that will be publicly known (products), use trade secrets for processes and algorithms not visible to public.

---

このスキルの目的は、組織の知的財産戦略を支援し、特許調査、特許性評価、FTO分析、特許ポートフォリオ分析を通じて、競争優位性を確保し、特許侵害リスクを最小化することです。適切な特許戦略により、イノベーションを保護し、ビジネス価値を最大化してください。